The neutrophil–lymphocyte ratio as a risk factor for all-cause mortality among individuals with resolved HBV infection: evidence from the NHANES 1999–2018
Open Access
- 15 January 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1493439
Abstract
Background: Inflammation is a critical component in the process of resolved hepatitis B virus (HBV) infection. The neutrophil-to-lymphocyte ratio (NLR) serves as a sensitive indicator of systemic inflammation and immune activation. Our study aimed to investigate the correlation between elevated NLR levels and the risk of all-cause mortality in patients with resolved HBV infection. Additionally, we evaluated the potential mediating effect of diabetes mellitus (DM) on this correlation.Methods: Our study enrolled 1,146 adult patients with resolved HBV infection from the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2018. We utilized the Restricted Cubic Splines (RCS) and Maximum Selection Rank Statistical Method (MSRSM) to analyze the relationship between the NLR and the risk of all-cause mortality. The impact of NLR was evaluated using a weighted multivariate Cox regression model, and the model’s predictive accuracy was assessed using time-dependent Receiver Operating Characteristic (ROC) curves. An intermediary analysis was conducted to explore the potential influence of DM on the observed relationship.Results: During follow-up period of 103.54 ± 4.90 months, we recorded 207 deaths among the study participants. The analysis using the RCS method revealed a significant positive correlation between the NLR and the risk of all-cause mortality. Those with elevated NLR levels faced a substantially higher mortality risk compared to those with lower levels, as indicated by a Hazard Ratio (HR) of 1.84, with a 95% Confidence Interval (CI) of 1.17 to 2.89 (p < 0.05). The predictive accuracy of the model was substantial, as evidenced by the Area Under the Curve (AUC) for ROC curves at 3, 5, and 10 years, which were 0.873, 0.870, and 0.862, respectively. Furthermore, mediation analysis indicated that DM significantly influenced the relationship between the NLR and mortality, with a mediation effect of 6.57% (95% Confidence Interval [CI]: 0.64 to 15%; p = 0.02).Conclusion: Elevated NLR is significantly associated with an increased risk of all-cause mortality in patients with resolved HBV infection. Concurrently, DM acts as a partial mediator of this association.Keywords
This publication has 38 references indexed in Scilit:
- Global Burden and Trends of Primary Liver Cancer Attributable to Comorbid Type 2 Diabetes Mellitus Among People Living with Hepatitis B: An Observational Trend Study from 1990 to 2019Journal of Epidemiology and Global Health, 2024
- Hepatitis B Virus Status and Clinical Outcomes in IgA NephropathyKidney International Reports, 2024
- The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise reviewThe Kaohsiung Journal of Medical Sciences, 2023
- Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis: results from the HEBEM studyJournal of Neurology, 2023
- Effect of Anti-HBs on Mortality Among Resolved HBV Infection: a Population-Based Prospective Cohort StudyInfectious Diseases and Therapy, 2023
- Prevalence of Cirrhosis/Advanced Fibrosis Among HBsAg-Negative and HBcAb-Positive US Adults: A Nationwide Population-Based StudyInfectious Diseases and Therapy, 2022
- Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta‐analysisHepatology, 2017
- Innate lymphoid cells in intestinal immunity and inflammationCellular and Molecular Life Sciences, 2015
- The Association Between Diabetes and Hepatocellular Carcinoma: A Systematic Review of Epidemiologic EvidenceClinical Gastroenterology and Hepatology, 2006
- Severe clinical course of de novo hepatitis B infection after liver transplantationLiver Transplantation and Surgery, 1999